Our network

The “lifespin family” now consists of experts from a wide range of disciplines. They support our vision – as employees, shareholders, cooperation partners or as active members of the scientific advisory board. Their experience spans all scientific fields and covers a wide range of entrepreneurial experience.
They are all united by the desire to help shape the diagnostics of tomorrow.

Exemplary voices

Lifespin’s propriety platform for the analysis of metabolites will disrupt how clinical chemistry is done and drive individualized medicine.

Prof. Dr. Felix Wieland

Senior Professor for Biochemistry at Heidelberg University
Elected Member of the Academia Europea and the National Academy of Sciences,
Honorary member of the Charité
Nearly all diseases are somehow linked to metabolism, which makes Lifespin’s technology so powerful.

Prof. Dr. James Rothman

Sterling Professor of cell biology at Yale University
Nobel Prize in Physiology/ Medicine 2013
concurrently, among other positions, Chairman of the Yale School of Medicine’s
Department of Cell Biology
As the past Director of the Human Genome Project for US Department of Energy, Dr. Hawkins has built a recognized career in the healthcare industry over the past 30 years spanning business, academic innovation and as an entrepreneur. He sits on several Boards and is currently writing a book on the impact of COVID on global healthcare networks. Dr. Hawkins has published over 50 peer-reviewed articles on automation, genomics, human diseases and the human genome project as well as inventing and patenting the use of magnetic beads for nucleic acids purification.

Dr. Trevor L. Hawkins

The cooperation with lifespin has opened up new possibilities for our research focus liquid biopsy. The analysis of metabolomic changes in blood plasma-based liquid biopsies represents a new level in our field of research and contributes to both the further understanding of tumor disease progression and the development of prognostic and predictive biomarkers.

The direct and straightforward collaboration with lifespin has led to a rapid implementation of ideas and project concepts. Overall, the cooperation with lifespin is a great enrichment for our projects, so we are looking forward to the planned further collaboration.

Prof. Dr. med. Rainer Claus

Comprehensive Cancer Center Augsburg (CCCA)
Senior Physician and Scientific Director
University Hospital Augsburg

Since last year lifespin has been supporting us in the analysis of the metabolomic course after stem cell transplantation and the investigation of the metabolite profile of CLL patients.

Lifespin has given us a detailed insight into their promising technology. An additional, enormously positive aspect of the collaboration is the number of parameters output. But it’s not just the technical know-how, but also the efficiency with which lifespin works and the constructive and open communication that have convinced us across the board.

We look forward to a long-term collaboration!

Prof. Dr. med. Dimitrios Mougiakakos MHBA

Research Group for Translational Tumor and Transplantation Immunology
Managing Senior Physician
University Hospital Erlangen
Lifespin’s innovative qNMR technology provides us with new and comprehensive metabolic data for our clinical studies of chronic liver diseases in humans.

Dr. rer. nat. Werner Dammermann

Center for Internal Medicine II
Brandenburg University Hospital
Brandenburg Medical School
When I joined lifespin in 2018, I was immediately fascinated by the concept, the intellectual challenge and the inspiring team. The method developed by lifespin for the automated identification and quantification of large and small molecules using an NMR spectrum is, to my knowledge, unsurpassed in terms of both molecule number and quantification accuracy. Even today, after accepting a professorship, I always enjoy being at lifespin. It is a pleasure for me to know and accompany this company.

Prof. Dr. Andreas Krumpel

Bioengineering/ Physics and Mathematics
Weihenstephan University of Applied Sciences

Contact us for more Information for Partnering and Investment Opportunities

Scroll to Top